Privia Health (PRVA) Cash from Financing Activities (2020 - 2026)

Privia Health has reported Cash from Financing Activities for 7 years, with the latest figure at -$10.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 575.7% year-over-year to -$10.7 million; the trailing twelve-month figure through Mar 2026 stood at -$6.2 million (down 201.79% YoY), and the FY2025 full-year result was $6.7 million, up 54.64% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$10.7 million, down from $2.1 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $8.6 million in Q3 2022, with the low at -$30.9 million in Q2 2022.
• Average Cash from Financing Activities over 5 years is -$918000.0, with a median of $1.5 million recorded in 2023.
• Year-over-year, Cash from Financing Activities soared 9319.35% in 2022 and tumbled 575.7% in 2026.
• Tracing PRVA's Cash from Financing Activities over 5 years: stood at $2.0 million in 2022, then sank by 97.85% to $42000.0 in 2023, then surged by 1373.81% to $619000.0 in 2024, then surged by 246.53% to $2.1 million in 2025, then slumped by 597.44% to -$10.7 million in 2026.
• The last three Cash from Financing Activities figures came in at -$10.7 million (Q1 2026), $2.1 million (Q4 2025), and $431000.0 (Q3 2025), per Business Quant data.

Peer Comparison